The Shift Toward Minimally Invasive Breast Cancer Care
Breast cancer management continues to evolve towards surgical de-escalation. Specifically, the axillary surgery prediction model provides clinicians with a reliable tool for identifying low-risk patients. This retrospective study analyzed over eight thousand patients to determine if imaging could predict sentinel lymph node involvement. Consequently, surgeons may now consider omitting invasive procedures in specific subgroups. The researchers utilized multivariate logistic regression to isolate independent predictors of metastasis. Additionally, they validated the tool using a training-validation split and a visual nomogram.
Implementing the Axillary Surgery Prediction Model
Furthermore, the study identified several key factors associated with node involvement. These variables include clinical T2 stage, lymphovascular invasion, and the ER+/HER2- subtype. High Ki-67 levels also significantly increased the risk profile for many patients. However, the combination of ultrasonography and MRI showed the highest predictive accuracy for negative nodal status. Patients with negative imaging findings across both modalities exhibited a remarkably low risk of sentinel lymph node metastasis. Notably, these results suggest that certain individuals can safely forgo axillary staging without compromising oncologic safety.
Clinical Significance of Multimodal Imaging
Moreover, the integration of advanced imaging aligns with current global shifts in oncology. Recent guidelines from major societies now support the omission of surgery in select postmenopausal populations. This shift aims to reduce the incidence of lymphedema and other surgical complications. Therefore, clinicians should use this prediction model to personalize treatment plans for early-stage breast cancer. Finally, this approach balances the need for accurate staging with the goal of improving long-term quality of life for survivors.
Frequently Asked Questions
Q1: What are the primary predictors used in this model?
The model incorporates clinical factors such as tumor stage, lymphovascular invasion, molecular subtype, and Ki-67 levels, alongside findings from axillary ultrasound and MRI.
Q2: How does the model help in avoiding unnecessary surgery?
By accurately identifying patients with a very low risk of lymph node metastasis, the model allows clinicians to safely omit sentinel lymph node biopsies in specific subgroups.
References
- Xie H et al. Prediction model to prevent axillary surgery using axillary US and MRI in early breast cancer. Eur Radiol. 2026 Apr 02. doi: 10.1007/s00330-026-12494-8. PMID: 41927980.
- Park KU et al. Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline clinical insights. JCO Oncol Pract. 2025. doi: 10.1200/OP-25-00447.
- Ha et al. Comparison of MRI and Ultrasound for Evaluation of Axillary Lymph Node Status in Early Breast Cancer. Dove Med Press. 2024. doi: 10.2147/BCTT.S488123.